Shanghai Biopharmaleader co.,ltd

Date: 18th July 2016
Baricitinib CAS:1187594-09-7
If you are going to consult the information about 1187594-09-7 from one of the leading 1187594-09-7 manufacturers and suppliers in China, Biopharmaleader Co.,Ltd is always at your service.Product InformationCAS NO.1187594-09-7?Product NameBaricitinibSynonymsINCB028050;LY3009104FormulaC16H17N7O2SMolecular Weight371.41Spec / Purity98%minSupply CapacityDetailsBaricitinib (INCB28050, LY3009104) is an oral JAK1 and JAK2 inhibitor. Baricitinib is in Phase III development as a potential treatment for rheumatoid arthritis. It is in Phase II development as a potential treatment for psoriasis and diabetic nephropathy. The related compound in JAK inhibitor is Tofacitinib, currently approved for the treatment of rheumatoid arthritis in the United States.
Images
Latest News
Contact Information
Phone:
86-021-50180596
Fax:

86-021-57758967

Address:

Building 11, NO. 3802 ShenGang Rd, Xinfei Corporation Home, SongJiang District, Shanghai,201611, China.
Shanghai, 201611

Website:

www.biopharmaleader.net

Contact Form